Additional Benefits of Rituximab and Plasma Exchange on Top of Standard Induction Therapy in Kidney Transplant Recipients With a Negative CDC Crossmatch but High Preformed Donor Specific Antibody Titer

Optimal induction strategy in highly sensitized kidney transplant recipients (KTRs) is still a matter of debate. The place of therapies, such as plasma exchange and rituximab, with potential side effects and high cost, is not clearly established. We compared two induction strategies with (intensive)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamadou, Inna, Matignon, Marie, Malard, Stéphanie, Lombardi, Yannis, Buob, David, Moktefi, Anissa, Jamme, Matthieu, Ouali, Nacera, Rafat, Cedric, François, Hélène, Petit-Hoang, Camille, Rondeau, Eric, Mesnard, Laurent, Grimbert, Philippe, Taupin, Jean-Luc, Luque, Yosu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088221/
https://www.ncbi.nlm.nih.gov/pubmed/37056357
http://dx.doi.org/10.3389/ti.2023.10844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088221/
https://www.ncbi.nlm.nih.gov/pubmed/37056357
http://dx.doi.org/10.3389/ti.2023.10844

Ejemplares similares